Your browser doesn't support javascript.
loading
Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups.
Bakerly, Nawar Diar; Woodcock, Ashley; Collier, Susan; Leather, David A; New, John P; Crawford, Jodie; Harvey, Catherine; Vestbo, Jørgen; Boucot, Isabelle.
Afiliación
  • Bakerly ND; Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK; Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre, The University of Manchester, Oxford Rd, Manchester, M13 9PL, UK. Electronic address: nawar.bakerly@srft.nhs.uk.
  • Woodcock A; Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre, The University of Manchester, Oxford Rd, Manchester, M13 9PL, UK; Manchester University NHS Foundation Trust, Manchester, UK. Electronic address: ashley.woodcock@manchester.ac.uk.
  • Collier S; UK Medical, GlaxoSmithKline plc., Stockley Park West, 1-3 Ironbridge Road, Uxbridge, Middlesex, UB11 1BT, UK. Electronic address: sue.d.collier@gsk.com.
  • Leather DA; Global Respiratory Franchise, GlaxoSmithKline plc., 980 Great West Rd, Brentford, Middlesex, TW8 9GS, UK. Electronic address: david.a.leather@gsk.com.
  • New JP; Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK. Electronic address: john.p.new@manchester.ac.uk.
  • Crawford J; Clinical Statistics, GlaxoSmithKline plc., Stockley Park West, 1-3 Ironbridge Road, Uxbridge, Middlesex, UB11 1BT, UK. Electronic address: jodie.v.crawford@gsk.com.
  • Harvey C; Global Clinical Safety & Pharmacovigilance, Safety Evaluation and Risk Management, GlaxoSmithKline plc., Stockley Park West, 1-3 Ironbridge Road, Uxbridge, Middlesex, UB11 1BT, UK. Electronic address: cath_m_harvey@gsk.com.
  • Vestbo J; Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre, The University of Manchester, Oxford Rd, Manchester, M13 9PL, UK; Manchester University NHS Foundation Trust, Manchester, UK. Electronic address: Jorgen.Vestbo@manchester.ac.uk.
  • Boucot I; Global Respiratory Franchise, GlaxoSmithKline plc., 980 Great West Rd, Brentford, Middlesex, TW8 9GS, UK. Electronic address: isabelle.i.boucot@gsk.com.
Respir Med ; 147: 58-65, 2019 02.
Article en En | MEDLINE | ID: mdl-30704700
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: Alcoholes Bencílicos / Clorobencenos / Enfermedad Pulmonar Obstructiva Crónica / Androstadienos / Pulmón Tipo de estudio: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Med Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: Alcoholes Bencílicos / Clorobencenos / Enfermedad Pulmonar Obstructiva Crónica / Androstadienos / Pulmón Tipo de estudio: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Med Año: 2019 Tipo del documento: Article